AN OPEN LABEL, SINGLE ARM, PHASE I/II STUDY TO ASSESS THE SAFETY AND EFFICACY OF PERIANAL ADMINISTRATION OF STEMPEUCEL® (ADULT HUMAN BONE MARROW DERIVED, CULTURED, POOLED, ALLOGENEIC MESENCHYMAL STROMAL CELLS) IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE

被引：0
|
作者：
Gupta, P. K. [1 ]
Kumar, U. [1 ]
Shanmugam, S. Subramanian [1 ]
Swaroop, S. [2 ]
Ahuja, V. [2 ]
机构：
[1] Stempeut Res, Bangalore, Karnataka, India
[2] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
来源：
CYTOTHERAPY | 2024年 / 26卷 / 06期
关键词：
Perianal fistuala due to Crohn's disease; Stempeucel; Mesenchymal stromal cells;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
28
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 48 条
  • [21] Local peri-fistula injection of allogeneic human amnion epithelial cells is a safe and promising treatment for refractory complex fistulizing perianal Crohn's disease: A Phase I open-label study
    Keung, C.
    Nguyen, T. C.
    Lim, R.
    Gerstenmaier, A.
    Sievert, W.
    Moore, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 133 - 134
  • [22] Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial
    Maciel Gutierrez, Victor Manuel
    Gutierrez Guillen, Sergio Giovanni
    Centeno Flores, Manuel Willebaldo
    Valenzuela Perez, Jesus Alonso
    Abarca Rendon, Francisco Manuel
    Hernandez Garcia, Fernando Santiago
    De la Cerda Trujillo, Liliana Faviola
    Gomez Torres, Gustavo Angel
    DISEASES OF THE COLON & RECTUM, 2021, 64 (03) : 328 - 334
  • [23] LOCAL PERI-FISTULA INJECTION OF A NOVEL PLACENTA-DERIVED CELL IS A SAFE AND PROMISING TREATMENT FOR REFRACTORY COMPLEX FISTULIZING PERIANAL CROHN'S DISEASE: A PHASE I OPEN LABEL STUDY
    Keung, Charlotte
    Nguyen, Thang Chien
    Lim, Rebecca
    Gerstenmaier, Angela
    Sievert, William
    Moore, Gregory T.
    GASTROENTEROLOGY, 2022, 162 (07) : S4 - S5
  • [24] Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease
    Molendijk, I.
    Bonsing, B. A.
    Roelofs, H.
    Peeters, K. C.
    Wasser, M. N.
    Veenendaal, R. A.
    Zwaginga, J. J.
    Verspaget, H. W.
    Fibbe, W. E.
    van der Meulen-de Jong, A. E.
    Hommes, D. W.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S254 - S255
  • [25] Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non-Crohn's cases: Clinical trial phase I
    Pak, Haleh
    Hadizadeh, Alireza
    Heirani-Tabasi, Asieh
    Soleimani, Masoud
    Asbagh, Reza Akbari
    Fazeli, Mohammad Sadegh
    Kazemeini, Alireza
    Keshvari, Amir
    Keramati, Mohammad Reza
    Salahshour, Faezeh
    Nazari, Hengameh
    Tafti, Seyed Mohsen Ahmadi
    Behboudi, Behnam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (04) : 539 - 547
  • [26] Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up
    Keung, Charlotte
    Nguyen, Thang Chien
    Lim, Rebecca
    Gerstenmaier, Angela
    Sievert, William
    Moore, Gregory T.
    EBIOMEDICINE, 2023, 98
  • [27] Phase I Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients with Connective Tissue Disorders
    Abril, Andy
    Mira-Avendano, Isabel
    Durand, Nisha
    Baig, Hassan
    Lee, Augustine
    Baer, Meghan
    Zubair, Abba
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2987 - 2989
  • [28] Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial
    Nabavi, Seyed Massood
    Arab, Leila
    Jarooghi, Neda
    Bolurieh, Tina
    Abbasi, Fatemeh
    Mardpour, Soura
    Azimyian, Vajihe
    Moeininia, Fatemeh
    Maroufizadeh, Saman
    Sanjari, Leila
    Hosseini, Seyedeh Esmat
    Aghdami, Nasser
    CELL JOURNAL, 2019, 20 (04) : 592 - 598
  • [29] Safety and Efficacy of Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus: Results of an Open-Label Phase I Study
    Kamen, Diane L.
    Nietert, Paul J.
    Wang, Hongjun
    Duke, Tara
    Cloud, Colleen
    Robinson, Angela
    Gilkeson, Gary S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
    Farge, Dominique
    Loisel, Severine
    Resche-Rigon, Matthieu
    Lansiaux, Pauline
    Colmegna, Ines
    Langlais, David
    Charles, Catney
    Pugnet, Gregory
    Maria, Alexandre Thibault Jacques
    Chatelus, Emmanuel
    Martin, Thierry
    Hachulla, Eric
    Kheav, Vissal David
    Lambert, Nathalie C.
    Wang, Han Chen
    Michonneau, David
    Martinaud, Christophe
    Sensebe, Luc
    Crast, Audrey
    Tarte, Karin
    LANCET RHEUMATOLOGY, 2022, 4 (02): : E91 - E104
12345